Gemini Therapeutics Price on April 14, 2021
GMTXDelisted Stock | USD 17.95 0.05 0.28% |
If you're considering investing in Gemini Stock, it is important to understand the factors that can impact its price. As of today, the current price of Gemini Therapeutics stands at 17.95, as last reported on the 28th of March, with the highest price reaching 19.20 and the lowest price hitting 16.05 during the day. We have found twenty-nine technical indicators for Gemini Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Gemini Therapeutics' Downside Deviation of 5.65, risk adjusted performance of 0.0455, and Market Risk Adjusted Performance of (0.34) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
Gemini Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Gemini |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
GMTX |
Based on monthly moving average Gemini Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gemini Therapeutics by adding Gemini Therapeutics to a well-diversified portfolio.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
MSFT | Microsoft | |
GOOG | Alphabet Class C | |
S | SentinelOne |
About Gemini Therapeutics Stock history
Gemini Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gemini is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gemini Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gemini Therapeutics stock prices may prove useful in developing a viable investing in Gemini Therapeutics
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration . Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts. Gemini Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.
Gemini Therapeutics Stock Technical Analysis
Gemini Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Gemini Therapeutics Period Price Range
Gemini Therapeutics March 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Gemini Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gemini Therapeutics shares will generate the highest return on investment. By undertsting and applying Gemini Therapeutics stock market strength indicators, traders can identify Gemini Therapeutics entry and exit signals to maximize returns
Gemini Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gemini Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Gemini Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gemini to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0455 | |||
Jensen Alpha | 0.6131 | |||
Total Risk Alpha | (1.13) | |||
Sortino Ratio | 0.0578 | |||
Treynor Ratio | (0.35) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Gemini Stock
If you are still planning to invest in Gemini Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gemini Therapeutics' history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |